Oak Asset Management, LLC Amgen Inc Transaction History

Oak Asset Management, LLC

  • $282 Million
  • Q3 2024

A detailed history of Oak Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Oak Asset Management, LLC holds 59,858 shares of AMGN stock, worth $15.5 Million. This represents 6.84% of its overall portfolio holdings.

Number of Shares
59,858
Previous 63,465 5.68%
Holding current value
$15.5 Million
Previous $19.8 Million 2.74%
% of portfolio
6.84%
Previous 7.27%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$309.38 - $337.38 $1.12 Million - $1.22 Million
-3,607 Reduced 5.68%
59,858 $19.3 Million
Q2 2024

Jul 12, 2024
SELL
$262.75 - $319.31 $18,918 - $22,990
-72 Reduced 0.11%
63,465 $19.8 Million
Q1 2024

Apr 17, 2024
SELL
$268.87 - $324.56 $43,556 - $52,578
-162 Reduced 0.25%
63,537 $18.1 Million
Q4 2023

Jan 23, 2024
BUY
$255.7 - $288.46 $55,231 - $62,307
216 Added 0.34%
63,699 $18.3 Million
Q3 2023

Oct 25, 2023
SELL
$218.65 - $271.46 $2,405 - $2,986
-11 Reduced 0.02%
63,483 $17.1 Million
Q2 2023

Aug 07, 2023
BUY
$214.27 - $253.37 $112,063 - $132,512
523 Added 0.83%
63,494 $14.1 Million
Q1 2023

Apr 14, 2023
BUY
$225.79 - $275.2 $129,151 - $157,414
572 Added 0.92%
62,971 $15.2 Million
Q4 2022

Feb 07, 2023
SELL
$229.03 - $291.01 $338,277 - $429,821
-1,477 Reduced 2.31%
62,399 $16.4 Million
Q3 2022

Oct 18, 2022
BUY
$224.46 - $253.15 $14.3 Million - $16.2 Million
63,876 New
63,876 $14.4 Million
Q2 2022

Jul 15, 2022
SELL
$230.71 - $256.74 $14.7 Million - $16.4 Million
-63,890 Closed
0 $0
Q1 2022

Apr 22, 2022
SELL
$219.27 - $242.57 $145,376 - $160,823
-663 Reduced 1.03%
63,890 $15.5 Million
Q4 2021

Feb 04, 2022
SELL
$198.88 - $227.6 $10,938 - $12,518
-55 Reduced 0.09%
64,553 $14.5 Million
Q3 2021

Oct 21, 2021
BUY
$212.27 - $248.7 $704,736 - $825,684
3,320 Added 5.42%
64,608 $13.1 Million
Q2 2021

Jul 14, 2021
BUY
$233.58 - $259.14 $368,122 - $408,404
1,576 Added 2.64%
61,288 $14.9 Million
Q1 2021

Apr 27, 2021
BUY
$221.91 - $258.6 $40,609 - $47,323
183 Added 0.31%
59,712 $14.9 Million
Q4 2020

Jan 20, 2021
BUY
$216.38 - $257.67 $62,750 - $74,724
290 Added 0.49%
59,529 $13.7 Million
Q3 2020

Oct 27, 2020
SELL
$234.65 - $260.95 $370,043 - $411,518
-1,577 Reduced 2.59%
59,239 $13.5 Million
Q2 2020

Jul 09, 2020
SELL
$197.81 - $242.74 $115,521 - $141,760
-584 Reduced 0.95%
60,816 $14.3 Million
Q1 2020

May 08, 2020
SELL
$182.24 - $241.7 $155,632 - $206,411
-854 Reduced 1.37%
61,400 $12.4 Million
Q4 2019

Jan 09, 2020
SELL
$189.21 - $243.2 $306,709 - $394,227
-1,621 Reduced 2.54%
62,254 $15 Million
Q3 2019

Oct 30, 2019
SELL
$174.11 - $208.62 $189,431 - $226,978
-1,088 Reduced 1.67%
63,875 $12.4 Million
Q2 2019

Jul 25, 2019
BUY
$166.7 - $195.41 $338,401 - $396,682
2,030 Added 3.23%
64,963 $11.4 Million
Q1 2019

May 06, 2019
BUY
$180.87 - $203.88 $1.53 Million - $1.72 Million
8,449 Added 15.51%
62,933 $12 Million
Q4 2018

Jan 17, 2019
BUY
$178.4 - $208.25 $695,224 - $811,550
3,897 Added 7.7%
54,484 $10.6 Million
Q3 2018

Oct 22, 2018
BUY
$185.29 - $208.89 $354,089 - $399,188
1,911 Added 3.93%
50,587 $10.5 Million
Q2 2018

Aug 01, 2018
BUY
$166.05 - $186.51 $1.19 Million - $1.33 Million
7,142 Added 17.2%
48,676 $8.99 Million
Q1 2018

Apr 23, 2018
SELL
$169.43 - $198.0 $27,278 - $31,878
-161 Reduced 0.39%
41,534 $7.08 Million
Q4 2017

Feb 13, 2018
BUY
$168.79 - $188.59 $7.04 Million - $7.86 Million
41,695
41,695 $7.25 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oak Asset Management, LLC Portfolio

Follow Oak Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email